Application 205976

Type
ANDA
Sponsor
PAR PHARM INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOPIRAMATETOPIRAMATECAPSULE, EXTENDED RELEASE;ORAL200MGNoNo
002TOPIRAMATETOPIRAMATECAPSULE, EXTENDED RELEASE;ORAL25MGNoNo
003TOPIRAMATETOPIRAMATECAPSULE, EXTENDED RELEASE;ORAL50MGNoNo
004TOPIRAMATETOPIRAMATECAPSULE, EXTENDED RELEASE;ORAL100MGNoNo